(Press-News.org) When children with conduct problems see images of others in pain, key parts of their brains don't react in the way they do in most people. This pattern of reduced brain activity upon witnessing pain may serve as a neurobiological risk factor for later adult psychopathy, say researchers who report their findings in the Cell Press journal Current Biology on May 2.
That's not to say that all children with conduct problems are the same, or that all children showing this brain pattern in young life will become psychopaths. The researchers emphasize that many children with conduct problems do not persist with their antisocial behavior.
"Our findings indicate that children with conduct problems have an atypical brain response to seeing other people in pain," says Essi Viding of University College London. "It is important to view these findings as an indicator of early vulnerability, rather than biological destiny. We know that children can be very responsive to interventions, and the challenge is to make those interventions even better, so that we can really help the children, their families, and their wider social environment."
Conduct problems represent a major societal problem and include physical aggression, cruelty to others, and a lack of empathy, or "callousness." In the United Kingdom, where the study was conducted, about five percent of children qualify for a diagnosis of conduct problems. But very little is known about the underlying biology.
In the new study, Viding, Patricia Lockwood, and their colleagues scanned children's brains by functional magnetic resonance imaging (fMRI) to see how those with conduct problems differ in their response to viewing images of others in pain.
The brain images showed that, relative to controls, children with conduct problems show reduced responses to others' pain specifically in regions of the brain known to play a role in empathy. The researchers also saw variation among those with conduct problems, with those deemed to be more callous showing lower brain activation than less callous individuals.
"Our findings very clearly point to the fact that not all children with conduct problems share the same vulnerabilities; some may have neurobiological vulnerability to psychopathy, while others do not," Viding says. "This raises the possibility of tailoring existing interventions to suit the specific profile of atypical processing that characterizes a child with conduct problems."
###
Current Biology, Lockwood et al.: "Association of Callous Traits with Reduced Neural Response to Others' Pain in Children with Conduct Problems." END
Kids with brains that under-react to painful images
2013-05-02
ELSE PRESS RELEASES FROM THIS DATE:
Bonding with your virtual self may alter your actual perceptions
2013-05-02
When people create and modify their virtual reality avatars, the hardships faced by their alter egos can influence how they perceive virtual environments, according to researchers.
A group of students who saw that a backpack was attached to an avatar that they had created overestimated the heights of virtual hills, just as people in real life tend to overestimate heights and distances while carrying extra weight, according to Sangseok You, a doctoral student in the school of information, University of Michigan.
"You exert more of your agency through an avatar when ...
An anarchic region of star formation
2013-05-02
NGC 6559 is a cloud of gas and dust located at a distance of about 5000 light-years from Earth, in the constellation of Sagittarius (The Archer). The glowing region is a relatively small object, just a few light-years across, in contrast to the one hundred light-years and more spanned by its famous neighbour, the Lagoon Nebula (Messier 8, eso0936 - http://www.eso.org/public/news/eso0936/). Although it is usually overlooked in favour of its distinguished companion, NGC 6559 has the leading role in this new picture.
The gas in the clouds of NGC 6559, mainly hydrogen, is ...
Adult cells transformed into early-stage nerve cells, bypassing the pluripotent stem cell stage
2013-05-02
MADISON, Wis. — A University of Wisconsin-Madison research group has converted skin cells from people and monkeys into a cell that can form a wide variety of nervous-system cells — without passing through the do-it-all stage called the induced pluripotent stem cell, or iPSC.
Bypassing the ultra-flexible iPSC stage was a key advantage, says senior author Su-Chun Zhang, a professor of neuroscience and neurology. "IPSC cells can generate any cell type, which could be a problem for cell-based therapy to repair damage due to disease or injury in the nervous system."
In ...
Gene variant appears to predict weight loss after gastric bypass
2013-05-02
Massachusetts General Hospital (MGH) researchers have identified a gene variant that helps predict how much weight an individual will lose after gastric bypass surgery, a finding with the potential both to guide treatment planning and to facilitate the development of new therapeutic approaches to treating obesity and related conditions like diabetes. The report receiving advance online publication in The American Journal of Human Genetics is the first to identify genetic predictors of weight loss after bariatric surgery.
"We know now that bypass surgery works not by ...
Study confirms everolimus can overcome trastuzumab resistance in HER-2 positive early breast cancer
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.
The study showed a statistically non-significant benefit in clinical response rates for some patients with early breast cancer when everolimus was added to treatment with trastuzumab. Yet the results suggest this benefit is achieved independently of the molecular pathways researchers expected would be involved.
Prof Mario Campone, Principal Investigator ...
Gene expression test distinguishes btw breast cancer patients at high & low risk of late recurrence
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A test that measures the expression levels of 58 genes in oestrogen receptor-positive breast cancers can effectively differentiate between patients who are at higher and lower risk for having their cancer recur elsewhere in the body more than five years after diagnosis, researchers report.
The new findings show that better individual risk prediction for women with these cancers is getting nearer, says study author Prof Michael Gnant from the Medical University of Vienna, Austria.
Prof Gnant reported the findings at the 5th IMPAKT ...
Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A new analysis has provided a comprehensive comparison of scores designed to predict which women with oestrogen-receptor positive breast cancer are at high risk of recurrence beyond five years after diagnosis, and may benefit from prolonged endocrine treatment.
The promising new findings will likely benefit the many women with oestrogen-receptor positive breast cancer whose cancer recurs more than five years after diagnosis, researchers told the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
The IMPAKT meeting presents ...
Study reveals magnitude of variation in gene expression measurements within breast cancers
2013-05-02
Lugano-CH, Brussels- BE, 2 May 2013 -- An important new study has revealed the clearest picture yet of precisely how much measurement variation influences gene expression profiles of breast cancer.
The results show, for the first time, which gene expression measurements may benefit from pooling of biopsies from a single tumour, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
These findings represent an important step toward allowing doctors to more precisely tailor an individual's treatment to a detailed analysis of their tumour's gene ...
Study opens new prospects for developing new targeted therapies for breast cancer
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
The IMPAKT meeting presents cutting edge, 'translational' breast cancer research that is beginning to have an impact for patients.
This current study was led by Dr Martine Piccart, Director of Medicine at the Jules ...
Breast cancer heterogeneity no barrier to predictive testing, study shows
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- Breast cancers contain many different cell types with different patterns of gene expression, but a new study provides reassurance that this variability should not be a barrier to using gene expression tests to help tailor cancer treatments to individual patients.
The findings were reported at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium. The IMPAKT meeting presents cutting edge, 'translational' breast cancer research that is beginning to have an impact for patients.
In recent years it has become clear that breast ...